Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0001415889-22-012077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-05 | 2022-12-01 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.73 | -2,084 | 313.5K | -0.7% | -$22.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-12-01 | S | D | 2,084 | $10.73 | 313,520 | D | — | — |